Recently, new avenues have opened up with the evaluation of different SCLC subtypes defined by the differential expression of four key transcription regulators: ASCL1, NeuroD1, YAP1 and POU2F3 (10). This evidence concerns the gene ASCL1 and small cell lung carcinoma.